GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity of Southern California

About this trial

This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient of the LA General gynecologic oncology clinic

Age 18 years or older

Previously obtained the HPV vaccination (initial chatbot evaluation)

Eligible for HPV vaccination (pilot intervention; age <46)

Disqualifiers

Patients who do not speak English or Spanish

Patients who do not provide informed consent

Patient of the LA General gynecologic oncology clinic

Age 18 years or older

Trial population

Patients of the LA General gynecologic oncology clinic who meet the eligibility criteria.

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

  • Non-Interventional Study

    Other intervention

    Non-interventional study

Treatment groups

48 Participants
are divided into 1 treatment group
Group A: Observational1 intervention

Trial outcomes

Primary outcomes

1

Patient Satisfaction Scores

Patients will complete a survey to assess their satisfaction with using an AI chatbot for HPV vaccine counseling.

Time frame
Up to 1 year
2

HPV Vaccination Rate

HPV vaccination rate for patients who received the HPV vaccine counseling with the AI-chatbot

Time frame
Up to 1 year

Secondary outcomes

1

Demographics of patients

Will be analyzed using a qualitative description of the demographics of patients involved in this specific study.

Time frame
Up to 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Southern California

Lead sponsor

National Cancer Institute (NCI)

Collaborator